Collectin CL-P1 utilizes C-reactive protein for complement activation

Biochimica et Biophysica Acta - General Subjects

Volumn 1860, Issue 6, 2016, Pages 1118-1128

  Roy, Nitai ^a   Ohtani, Katsuki ^a   Matsuda, Yasuyuki ^a   Mori, Kenichiro ^a   Hwang, Insu ^a   Suzuki, Yasuhiko ^b   Inoue, Norimitsu ^c   Wakamiya, Nobutaka ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

Author keywords

Classical pathway; Collectin; Complement; Pentraxin; Scavenger receptor

Indexed keywords

C REACTIVE PROTEIN; COLLECTIN; COLLECTIN PLACENTA 1; COMPLEMENT COMPONENT C1Q; COMPLEMENT FACTOR H; UNCLASSIFIED DRUG; COLEC12 PROTEIN, HUMAN; SCAVENGER RECEPTOR;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL PROTECTION; CHO CELL LINE; COMPLEMENT ACTIVATION; COMPLEMENT CLASSICAL PATHWAY; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEK293 CELL LINE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; ANIMAL; CHEMISTRY; CRICETULUS; HUMAN; PHYSIOLOGY;

ANIMALS; C-REACTIVE PROTEIN; CHO CELLS; COLLECTINS; COMPLEMENT ACTIVATION; COMPLEMENT FACTOR H; CRICETULUS; HEK293 CELLS; HUMANS; RECEPTORS, SCAVENGER;

EID: 84960194846     PISSN: 03044165     EISSN: 18728006     Source Type: Journal    
DOI: 10.1016/j.bbagen.2016.02.012     Document Type: Article

References (42)

1. C. Gabay, and I. Kushner Acute-phase proteins and other systemic responses to inflammation N. Engl. J. Med. 340 1999 448 454
2. B. Clyne, and J.S. Olshaker The C-reactive protein J. Emerg. Med. 17 1999 1019 1025
3. J.E. Volanakis, and M.H. Kaplan Interaction of C-reactive protein complexes with the complement system. II. Consumption of guinea pig complement by CRP complexes: Requirement for human C1q J. Immunol. 113 1974 9 17
4. S. Black, I. Kushner, and D. Samols C-reactive protein J. Biol. Chem. 279 2004 48487 48490
5. C. Gaboriaud, J. Juanhuix, A. Gruez, M. Lacroix, C. Darnault, D. Pignol, D. Verger, J.C. Fontecilla-Camps, and G.J. Arlaud The crystal structure of the globular head of complement protein C1q provides a basis for its versatile recognition properties J. Biol. Chem. 278 2003 46974 46982
6. A.J. Nauta, B. Bottazzi, A. Mantovani, G. Salvatori, U. Kishore, W.J. Schwaeble, A.R. Gingras, S. Tzima, F. Vivanco, J. Egido, O. Tijsma, E.C. Hack, M.R. Daha, and A. Roos Biochemical and functional characterization of the interaction between pentraxin 3 and C1q Eur. J. Immunol. 33 2003 465 473
7. B. Bottazzi, V. Vouret-Craviari, A. Bastone, L.D. Gioia, C. Matteucci, G. Peri, S. Spreafico, M. Pausa, C. D'Ettorrei, E. Gianazza, A. Tagliabuei, M. Salmona, F. Tedesco, M. Introna, and A. Mantovani Multimer formation and ligand recognition by the long pentraxin PTX3 J. Biol. Chem. 272 1997 32817 32823
8. T. Sawamura, N. Kume, T. Aoyama, H. Moriwaki, H. Hoshikawa, Y. Aiba, T. Tanaka, S. Miwa, Y. Katsura, T. Kita, and T. Misaki An endothelial receptor for oxidized-low density lipoprotein Nature 386 1997 73 77
9. Y. Fujita, S. Yamaguchi, A. Kakino, S. Iwamoto, R. Yoshimoto, and T. Sawamura Lectin-like oxidized LDL receptor 1 is involved in CRP-mediated complement activation Clin. Chem. 57 2011 101398 101405
10. Y. Fujita, A. Kakino, N. Nishimichi, S. Yamaguchi, Y. Sato, S. Machida, L. Cominacini, Y. Delneste, H. Matsuda, and T. Sawamura Oxidized LDL receptor LOX-1 binds to C-reactive protein and mediates its vascular effects Clin. Chem. 55 2009 2285 2294
11. Y. Fujita, A. Kakino, M. Harada-shiba, Y. Sato, K. Otsui, R. Yoshimoto, and T. Sawamura C-reactive protein uptake by macrophage cell line via class-A scavenger receptor Clin. Chem. 56 2010 478 481
12. K.J. Moore, and M.W. Freeman Scavenger receptors in atherosclerosis: Beyond lipid uptake Arterioscler. Thromb. Vasc. Biol. 26 2006 1702 1711
13. D.R. Greaves, and S. Gordon Thematic review series: The immune system and atherogenesis: Recent insights into the biology of macrophage scavenger receptors J. Lipid Res. 46 2005 11 20
14. K. Ohtani, Y. Suzuki, S. Eda, T. Kawai, T. Kase, H. Keshi, Y. Sakai, A. Fukuoh, T. Sakamoto, H. Itabe, T. Suzutani, M. Ogasawara, I. Yoshida, and N. Wakamiya The membrane-type collectin CL-P1 Is a scavenger receptor on vascular endothelial cells J. Biol. Chem. 276 2001 44222 44228
15. M. Prabhudas, D. Bowdish, K. Drickamer, M. Febbraio, J. Herz, L. Kobzik, M. Krieger, J. Loike, T.K. Means, S.K. Moestrup, S. Post, T. Sawamura, S. Silverstein, X.Y. Wang, and J. El Khoury Standardizing scavenger receptor nomenclature J. Immunol. 192 2014 1997 2006
16. http://www.gesnenames.org/genefamilies/COLEC
17. T. Kodama, M. Freeman, L. Rohrer, J. Zabrecky, P. Matsudaira, and M. Krieger Type I macrophage scavenger receptor contains alpha-helical and collagen-like coiled coils Nature 343 1990 531 535
18. S. Jang, K. Ohtani, A. Fukuoh, T. Yoshizaki, M. Fukuda, W. Motomura, K. Mori, J. Fukuzawa, N. Kitamoto, T. Yoshida, Y. Suzuki, and N. Wakamiya Scavenger receptor collectin placenta 1 (CL-P1) predominantly mediates zymosan phagocytosis by human vascular endothelial cells J. Biol. Chem. 284 2009 3956 3965
19. K. Mori, K. Ohtani, S. Jang, Y. Kim, I. Hwang, N. Roy, Y. Matsuda, Y. Suzuki, and N. Wakamiya Scavenger receptor CL-P1 mainly utilizes a collagen-like domain to uptake microbes and modified LDL Biochim. Biophys. Acta 1840 2014 3345 3356
20. Y.J. Ma, E. Hein, L. Munthe-Fog, M. Skjoedt, R. Bayarri-Olmos, L. Romani, and P. Garred Soluble collectin-12 (CL-12) is a pattern recognition molecule initiating complement activation via the alternative pathway J. Immunol. 195 2015 3365 3373
21. F.D.G. McGrath, M.C. Brouwer, G.J. Arlaud, M.R. Daha, C.E. Hack, and A. Roos Evidence that complement protein C1q interacts with C-reactive protein through its globular head region J. Immunol. 176 2006 2950 2957
22. E. Lipo, S.M. Cashman, and R. Kumar-Singh Aurintricarboxylic acid inhibits complement activation, membrane attack complex, and choroidal neovascularization in a model of macular degeneration Invest Opthalmol. 54 2013 7107 7114
23. A. Bíró, Z. Rovó, D. Papp, L. Cervenak, L. Varga, G. Füst, N.M. Thielens, G.J. Arlaud, and Z. Prohászka Studies on the interactions between C-reactive protein and complement proteins Immunology 121 2007 40 50
24. S. Berman, H. Gewurz, and C. Mold Binding of C-reactive protein to nucleated cells leads to complement activation without cytolysis J. Immunol. 136 1986 1354 1359
25. M. Aronen, T. Lehto, and S. Meri Regulation of the alternative pathway complement activation by an interaction of C-reactive protein with factor H Immunol. Infect. Dis. 3 1993 83 88
26. C. Mold, M.P. Stein, and T.W. Du Clos Regulation of complement by direct binding of factor H to C-reactive protein Mol. Immunol. 35 1998 346 350
27. D.P. Vik, P. Munoz-Canoves, D.D. Chaplin, B.F. Tack, and H. Factor Curr. Top. Microbiol. Immunol. 153 1990 147 162
28. R. Dicamelli, L.A. Potempa, J. Siegel, L. Suyehira, K. Petras, and H. Gewurz Binding reactivity of C-reactive protein for polycations J. Immunol. 125 1980 1933 1938
29. S. Black, A. Agrawal, and D. Samols The phosphocholine and the polycation-binding sites on rabbit C-reactive protein are structurally and functionally distinct Mol. Immunol. 39 2003 1045 1054
30. R.T. Lee, I. Takagahara, and Y.C. Lee Mapping the binding areas of human C-reactive protein for phosphorylcholine and polycationic compounds J. Biol. Chem. 277 2002 225 232
31. H.H. Shih, S. Zhang, W. Cao, A. Hahn, J. Wang, J.E. Paulsen, and D.C. Harnish CRP is a novel ligand for the oxidized LDL receptor LOX-1 Am. J. Physiol. Heart Circ. Physiol. 296 2009 1643 1650
32. M.V. Suresh, S.K. Singh, D.A. Ferguson Jr., and A. Agrawal Role of the property of C-reactive protein to activate the classical pathway of complement in protecting mice from pneumococcal infection J. Immunol. 176 2006 4369 4374
33. R.A. Rabinovitch, S.M. Koethe, J.H. Kalbfleisch, L.C. Preheim, and M.W. Rytel Relationships between alternative complement pathway activation, C-reactive protein, and pneumococcal infection J. Clin. Microbiol. 23 1986 56 61
34. C. Kemper, J.P. Atkinson, and D.E. Hourcade Properdin: Emerging roles of a pattern-recognition molecule Annu. Rev. Immunol. 28 2009 131 155
35. B.D. Gershov, S. Kim, N. Brot, and K.B. Elkon C-reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: Implications for systemic autoimmunity J. Exp. Med. 192 2000 1353 1363
36. A.L. Trouw, A.A. Bengtsson, A.Kyra. Gelderman, B. Dahlback, G. Sturfelt, and M.A. Blom C4b-binding protein and factor H compensate for the loss of membrane-bound complement inhibitors to protect apoptotic cells against excessive complement attack J. Biol. Chem. 282 2007 28540 28548
37. P.E. Szmitko, C.H. Wang, R.D. Weisel, G.A. Jeffries, T.J. Anderson, and S. Verma Biomarkers of vascular disease linking inflammation to endothelial activation part II Circulation 108 2003 2041 2048
38. B.M. Scirica, and D.A. Morrow Is C-reactive protein an innocent bystander or proatherogenic culprit? Circulation 113 2006 2128 2151
39. A. Paul, W.S. Ko, K., L. Li, V. Yechoor, M.A. McCrory, A.J. Szalai, and L. Chan C-reactive protein accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice Circulation 109 2004 647 655
40. G.M. Hirschfield, J.R. Gallimore, M.C. Kahan, W.L. Hutchinson, C.A. Sabin, G.M. Benson, A.P. Dhillon, G.A. Tennent, and M.B. Pepys Transgenic human C-reactive protein is not proatherogenic in apolipoprotein E-deficient mice Proc. Natl. Acad. Sci. U. S. A. 102 2005 8309 8314
41. A. Trion, M.P.M. de Maat, J.W. Jukema, A. van der Laarse, M.C. Maas, E.H. Offerman, L.M. Havekes, A.J. Szalai, H.M.G. Princen, and J.J. Emeis No effect of C-reactive protein on early atherosclerosis development in apolipoprotein E∗3-leiden/human C-reactive protein transgenic mice Arterioscler. Thromb. Vasc. Biol. 25 2005 1635 1640
42. T.W. Du Clos, and C. Mold Pentraxins (CRP, SAP) in the process of complement activation and clearance of apoptotic bodies through Fcγ receptors Curr. Opin. Organ Transplant. 16 2011 15 20